Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
Price to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
16.84
↓ 69% below average
Average (9y)
54.66
Historical baseline
Range
High:205.57
Low:4.57
CAGR
-24.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 16.84 | +31.7% |
| 2023 | 12.78 | -39.6% |
| 2022 | 21.18 | -16.8% |
| 2021 | 25.45 | -8.1% |
| 2020 | 27.70 | +506.1% |
| 2019 | 4.57 | -27.6% |
| 2018 | 6.31 | -77.7% |
| 2017 | 28.38 | -85.7% |
| 2016 | 197.81 | -3.8% |
| 2015 | 205.57 | - |